PR-924, a selective inhibitor of the immunoproteasome subunit LMP-7, blocks multiple myeloma cell growth both in vitro and in vivo.
Singh, Ajita V. 1; Bandi, Madhavi 1; Aujay, Monette A. 2; Kirk, Christopher J. 2; Hark, David E. 1; Raje, Noopur 1; Chauhan, Dharminder 1; Anderson, Kenneth C. 1
British Journal of Haematology.
152(2):155-163, January 2011.
(Format: HTML, PDF)